[go: up one dir, main page]

WO2006044548A3 - Clopidogrel compositions - Google Patents

Clopidogrel compositions Download PDF

Info

Publication number
WO2006044548A3
WO2006044548A3 PCT/US2005/036835 US2005036835W WO2006044548A3 WO 2006044548 A3 WO2006044548 A3 WO 2006044548A3 US 2005036835 W US2005036835 W US 2005036835W WO 2006044548 A3 WO2006044548 A3 WO 2006044548A3
Authority
WO
WIPO (PCT)
Prior art keywords
premixes
clopidogrel compositions
clopidogrel
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/036835
Other languages
French (fr)
Other versions
WO2006044548A2 (en
Inventor
Mamta Mishra
Arunava Ghosh
Gurvinder Singh
Billa Praveen Reddy
Mailatur Sivaraman Mohan
Indu Bhushan
Prasada Raju Venkata Vetukuri
Sreenadhacharyulu Kandala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Priority to EP05807697A priority Critical patent/EP1802280A4/en
Publication of WO2006044548A2 publication Critical patent/WO2006044548A2/en
Publication of WO2006044548A3 publication Critical patent/WO2006044548A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides clopidogrel base premixes with pharmaceutical excipients, pharmaceutical formulations containing the premixes, and their use in treatment of thrombotic disorders.
PCT/US2005/036835 2004-10-14 2005-10-14 Clopidogrel compositions Ceased WO2006044548A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05807697A EP1802280A4 (en) 2004-10-14 2005-10-14 Clopidogrel compositions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1067/CHE/2004 2004-10-14
IN1067CH2004 2004-10-14
US65046605P 2005-02-07 2005-02-07
US60/650,466 2005-02-07

Publications (2)

Publication Number Publication Date
WO2006044548A2 WO2006044548A2 (en) 2006-04-27
WO2006044548A3 true WO2006044548A3 (en) 2006-10-26

Family

ID=36203514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/036835 Ceased WO2006044548A2 (en) 2004-10-14 2005-10-14 Clopidogrel compositions

Country Status (2)

Country Link
EP (1) EP1802280A4 (en)
WO (1) WO2006044548A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
WO2010144339A2 (en) 2009-06-08 2010-12-16 Schering Corporation A thrombin receptor antagonist and clopidogrel fixed dose tablet
CN101766573B (en) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 Preparation process of clopidogrel bisulfate solid preparation
KR102487879B1 (en) * 2017-11-13 2023-01-12 주식회사유한양행 Process for preparing bi-layered tablet comprising rosuvastatin and clopidogrel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153078A1 (en) * 2001-10-30 2003-05-22 Degussa Use of granules based on pyrogenic silicon dioxide in pharmaceutical compositions
DE10305984A1 (en) * 2003-02-13 2004-09-02 Helm Ag Salts of organic acids with clopidogrel and their use in the manufacture of pharmaceutical formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1802280A4 *

Also Published As

Publication number Publication date
EP1802280A4 (en) 2008-02-20
EP1802280A2 (en) 2007-07-04
WO2006044548A2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
EP1622589A4 (en) Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2005123076A3 (en) Pharmaceutical compositions
TWI340138B (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2006050477A3 (en) Anti-microbial compositions and methods of making and using the same
WO2005041924A3 (en) Administration of levodopa and carbidopa
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
WO2004078116A3 (en) P38 inhibitors and methods of use thereof
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2006015263A3 (en) Lonidamine analogs
IL184051A (en) Acylated glp-1 compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2006124748A3 (en) Multicyclic compounds and methods of their use
MY135829A (en) Analeptic and drug combinations
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
AP2005003362A0 (en) Formulation and methods for the treatment of thrombocythemia.
MXPA03007126A (en) Parasiticidal compositions and methods of use.
UA84929C2 (en) Prodrugs of pyrrolylpyrimidine erk protein kinase inhibitors
AP2006003557A0 (en) Antimalarial compositions and process thereof.
WO2005030142A3 (en) Rifalazil formulations
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
WO2006091836A8 (en) Formulations of ladostigil tartrate
WO2006044548A3 (en) Clopidogrel compositions
WO2007076320A8 (en) Compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005807697

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005807697

Country of ref document: EP